Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Lacrimal passage irrigation fluid for nursing of pediatric dacryocystitis

A technology for dacryocystitis and irrigating fluid, applied in the field of lacrimal duct irrigating fluid for pediatric dacryocystitis nursing, can solve the problems of eye irritation in children, no adjuvant treatment for dacryocystitis, etc. Active and safe effects

Inactive Publication Date: 2017-01-04
高伟荣
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Most of the existing technologies use normal saline to flush the lacrimal sac, but normal saline has a certain stimulating effect on children's eyes. Besides, normal saline has no other auxiliary treatment effects on dacryocystitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A lacrimal duct irrigating solution for nursing care of children with dacryocystitis, comprising the following components in mass percentage: 0.01% L-ornidazole, 0.1% antimicrobial peptide, 0.01% L-borneol, 0.05% aescin, 0.02% cortex ketone, 0.02% allantoin, 0.03% naringenin, 0.005% shikimic acid, 0.003% cryptoxanthin, 0.01% vitamin A, 0.03% surfactant, and the balance is water for injection.

[0016] Wherein, the antibacterial peptide is polymyxin E, which has a wide antibacterial spectrum, no side effects, and high safety. The surfactant is polyoxyethylene sorbitan monooleate.

[0017] The preparation method of lacrimal duct irrigating liquid for nursing of this infantile dacryocystitis is:

[0018] Weigh L-ornidazole, antibacterial peptide, L-borneol, aescin, phellodendron, allantoin, naringenin, shikimic acid, cryptoxanthin, vitamin A, surfactant, water for injection according to the formula, and add vacuum In the emulsification homogenizer, under the condition of...

Embodiment 2

[0020] A lacrimal duct irrigating solution for nursing care of children with dacryocystitis, comprising the following components in mass percentage: 0.02% L-ornidazole, 0.2% antibacterial peptide, 0.015% L-borneol, 0.06% aescin, 0.06% cortex ketone, 0.03% allantoin, 0.04% naringenin, 0.015% shikimic acid, 0.023% cryptoxanthin, 0.03% vitamin A, 0.04% surfactant, and the balance is water for injection.

[0021] Wherein, the antibacterial peptide is polymyxin E, which has a wide antibacterial spectrum, no side effects, and high safety. The surfactant is polyoxyethylene sorbitan monooleate.

[0022] The preparation method of lacrimal duct irrigating liquid for nursing of this infantile dacryocystitis is:

[0023] Weigh L-ornidazole, antibacterial peptide, L-borneol, aescin, phellodendron, allantoin, naringenin, shikimic acid, cryptoxanthin, vitamin A, surfactant, water for injection according to the formula, and add vacuum In the emulsification homogenizer, under the condition o...

Embodiment 3

[0025] A lacrimal duct irrigating solution for nursing care of children with dacryocystitis, comprising the following components in mass percentage: 0.025% L-ornidazole, 0.3% antibacterial peptide, 0.02% L-borneol, 0.075% aescin, 0.11% cortex ketone, 0.035% allantoin, 0.055% naringenin, 0.0525% shikimic acid, 0.0535% cryptoxanthin, 0.055% vitamin A, 0.045% surfactant, and the balance is water for injection.

[0026] Wherein, the antibacterial peptide is polymyxin E, which has a wide antibacterial spectrum, no side effects, and high safety. The surfactant is polyoxyethylene sorbitan monooleate.

[0027] The preparation method of lacrimal duct irrigating liquid for nursing of this infantile dacryocystitis is:

[0028] Weigh L-ornidazole, antibacterial peptide, L-borneol, aescin, phellodendron, allantoin, naringenin, shikimic acid, cryptoxanthin, vitamin A, surfactant, water for injection according to the formula, and add vacuum In the emulsification homogenizer, fully stir and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
pore sizeaaaaaaaaaa
pore sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses lacrimal passage irrigation fluid for nursing of pediatric dacryocystitis. The lacrimal passage irrigation fluid is prepared from, by mass, 0.01-0.04% of (S)-ornidazole, 0.1-0.5% of antibacterial peptide, 0.01-0.03% of L-borneolum, 0.05-0.1% of aescin, 0.02-0.2% of obakunone, 0.02-0.05% of allantoin, 0.03-0.08% of naringenin, 0.005-0.1% of shikimic acid, 0.003-0.1% of cryptoxanthin, 0.01-0.1% of vitamin A, 0.03-0.06% of a surfactant and the balance water for injection. Compared with existing normal saline irrigation fluid, the lacrimal passage irrigation fluid for nursing of pediatric dacryocystitis has advantages that antibacterial and anti-inflammation effects are achieved, infection caused by anaerobic bacteria can be controlled especially, postoperative recovery of lacrimal duct probing is promoted, neural activity can be protected, and a function of maintaining eyesight health can be achieved to some extent.

Description

technical field [0001] The invention relates to the technical field of nursing medicine for dacryocystitis, in particular to a lacrimal duct flushing solution for nursing of dacryocystitis in children. Background technique [0002] Neonatal dacryocystitis is caused by secondary infection caused by the retention of tear fluid and bacteria in the lacrimal sac because the embryonic residual membrane at the lower end of the nasolacrimal duct does not degenerate and blocks the lower end of the nasolacrimal duct. Neonatal dacryocystitis is a relatively common eye disease, and the baby's eyes are often teary. There are a lot of thick secretions in the baby's eyes, and the age of onset can be early or late. Some have symptoms on the first day after birth, and some may appear about a week or a month later. Neonatal long-term dacryocystitis is a serious threat to the safety of the eyes. Progressive corneal ulcer or penetrating eye injury, intraocular surgery, etc. can cause panophth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/12A61K9/08A61P27/02A61P31/04A61K31/4164A61K31/704A61K31/4166A61K31/352A61K31/19A61K31/07A61K31/045A61K31/585
CPCA61K9/0048A61K9/08A61K31/045A61K31/07A61K31/19A61K31/352A61K31/4164A61K31/4166A61K31/585A61K31/704A61K38/12A61K47/26A61K2300/00
Inventor 高伟荣王金霞王夕花
Owner 高伟荣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com